Suppr超能文献

白吉利丝孢酵母对抗真菌药物的体外敏感性

In vitro susceptibility of Trichosporon beigelii to antifungal agents.

作者信息

Perparim K, Nagai H, Hashimoto A, Goto Y, Tashiro T, Nasu M

机构信息

Second Department of Internal Medicine, Oita Medical University, Japan.

出版信息

J Chemother. 1996 Dec;8(6):445-8. doi: 10.1179/joc.1996.8.6.445.

Abstract

The minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) of amphotericin B, flucytosine, miconazole, fluconazole and itraconazole against 21 isolates of Trichosporon beigelii in RPMI-1640 medium were determined using National Committee for Clinical Laboratory Standards (NCCLS) methodology in microdilution method. Most isolates were sensitive to miconazole (MIC90 0.78 microgram/ml), fluconazole (MIC90 6.25 micrograms/ml), and itraconazole (MIC90 0.19 microgram/ml), with the former being the most active agent tested (MFC90 3.12 mu/ml). Although amphotericin B inhibited most strains (MIC range, 0.78-3.12 micrograms/ml), poor fungicidal activity was observed (MFC range, 1.56-12.5 micrograms/ml) showing a pattern of relative resistance in vitro. Flucytosine showed generally poor activity against most isolates tested. These in vitro findings confirm the resistance of T.beigelii to amphotericin B and suggest that azoles may be an alternative to the former for the treatment of disseminated trichosporonosis. However, in vivo studies would better validate these in vitro findings.

摘要

采用美国国家临床实验室标准委员会(NCCLS)微量稀释法,在RPMI - 1640培养基中测定了两性霉素B、氟胞嘧啶、咪康唑、氟康唑和伊曲康唑对21株白吉利丝孢酵母的最低抑菌浓度(MIC)和最低杀菌浓度(MFC)。大多数分离株对咪康唑(MIC90为0.78微克/毫升)、氟康唑(MIC90为6.25微克/毫升)和伊曲康唑(MIC90为0.19微克/毫升)敏感,其中咪康唑是所测试的最具活性的药物(MFC90为3.12微克/毫升)。虽然两性霉素B抑制了大多数菌株(MIC范围为0.78 - 3.12微克/毫升),但观察到其杀菌活性较差(MFC范围为1.56 - 12.5微克/毫升),显示出体外相对耐药模式。氟胞嘧啶对大多数测试分离株的活性普遍较差。这些体外研究结果证实了白吉利丝孢酵母对两性霉素B耐药,并表明唑类药物可能是治疗播散性白吉利丝孢酵母病替代两性霉素B的药物。然而,体内研究将能更好地验证这些体外研究结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验